Additionally, indirect targeting of YAP/TAZ aims to target the signaling pathways that abnormally regulate YAP/TAZ activation in tumor cells, which theoretically has less impact on the functional requirements of YAP/TAZ by damaging normal cells, and therefore has better precision in terms of strategy. This evidence concerns the gene YAP1 and neoplasm.